Global Blood-Brain Barrier Transport Drugs Market Analysis 2015-2019 and Forecast 2020-2025

99S3753804
119 Pages
February 2020
Healthcare

Download Sample Get Discount

Snapshot

The global Blood-Brain Barrier Transport Drugs market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Blood-Brain Barrier Transport Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Carrier-mediated Transport

Receptor-mediated Transport

Absorptive-mediated Transport

Active Efflux Transport

Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

Cyclenium

BioAdvance

EIP Pharma

Bioasis

Immune Pharmaceuticals

AZ Therapies

Palobiofarma

Bach Pharma

BrainsGate

CarThera

Dainippon Sumitomo Pharma

Fluorinov Pharma

Fondazione Telethon

Minoryx

NewGen Therapeutics

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Alzheimer's Disease

Epilepsy

Parkinson's Disease

Multiple Sclerosis

Hunter's Syndrome

Brain Cancer

Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Table of Contents

1 Industry Overview

1.1 Blood-Brain Barrier Transport Drugs Industry

Figure Blood-Brain Barrier Transport Drugs Industry Chain Structure

1.1.1 Overview

1.1.2 Development of Blood-Brain Barrier Transport Drugs

1.2 Market Segment

1.2.1 Upstream

Table Upstream Segment of Blood-Brain Barrier Transport Drugs

1.2.2 Downstream

Table Application Segment of Blood-Brain Barrier Transport Drugs

Table Global Blood-Brain Barrier Transport Drugs Market 2015-2025, by Application, in USD Million

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Blood-Brain Barrier Transport Drugs Market by Type

3.1 By Type

3.1.1 Carrier-mediated Transport

Table Major Company List of Carrier-mediated Transport

3.1.2 Receptor-mediated Transport

Table Major Company List of Receptor-mediated Transport

3.1.3 Absorptive-mediated Transport

Table Major Company List of Absorptive-mediated Transport

3.1.4 Active Efflux Transport

Table Major Company List of Active Efflux Transport

3.1.5 Others

Table Major Company List of Others

3.2 Market Size

Table Global Blood-Brain Barrier Transport Drugs Market 2015-2019, by Type, in USD Million

Figure Global Blood-Brain Barrier Transport Drugs Market Growth 2015-2019, by Type, in USD Million

Table Global Blood-Brain Barrier Transport Drugs Market 2015-2019, by Type, in Volume

Figure Global Blood-Brain Barrier Transport Drugs Market Growth 2015-2019, by Type, in Volume

3.3 Market Forecast

Table Global Blood-Brain Barrier Transport Drugs Market Forecast 2020-2025, by Type, in USD Million

Table Global Blood-Brain Barrier Transport Drugs Market Forecast 2020-2025, by Type, in Volume

4 Major Companies List

4.1 Cyclenium (Company Profile, Sales Data etc.)

4.1.1 Cyclenium Profile

Table Cyclenium Overview List

4.1.2 Cyclenium Products & Services

4.1.3 Cyclenium Business Operation Conditions

Table Business Operation of Cyclenium (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.2 BioAdvance (Company Profile, Sales Data etc.)

4.2.1 BioAdvance Profile

Table BioAdvance Overview List

4.2.2 BioAdvance Products & Services

4.2.3 BioAdvance Business Operation Conditions

Table Business Operation of BioAdvance (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.3 EIP Pharma (Company Profile, Sales Data etc.)

4.3.1 EIP Pharma Profile

Table EIP Pharma Overview List

4.3.2 EIP Pharma Products & Services

4.3.3 EIP Pharma Business Operation Conditions

Table Business Operation of EIP Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.4 Bioasis (Company Profile, Sales Data etc.)

4.4.1 Bioasis Profile

Table Bioasis Overview List

4.4.2 Bioasis Products & Services

4.4.3 Bioasis Business Operation Conditions

Table Business Operation of Bioasis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.5 Immune Pharmaceuticals (Company Profile, Sales Data etc.)

4.5.1 Immune Pharmaceuticals Profile

Table Immune Pharmaceuticals Overview List

4.5.2 Immune Pharmaceuticals Products & Services

4.5.3 Immune Pharmaceuticals Business Operation Conditions

Table Business Operation of Immune Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.6 AZ Therapies (Company Profile, Sales Data etc.)

4.6.1 AZ Therapies Profile

Table AZ Therapies Overview List

4.6.2 AZ Therapies Products & Services

4.6.3 AZ Therapies Business Operation Conditions

Table Business Operation of AZ Therapies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.7 Palobiofarma (Company Profile, Sales Data etc.)

4.7.1 Palobiofarma Profile

Table Palobiofarma Overview List

4.7.2 Palobiofarma Products & Services

4.7.3 Palobiofarma Business Operation Conditions

Table Business Operation of Palobiofarma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.8 Bach Pharma (Company Profile, Sales Data etc.)

4.8.1 Bach Pharma Profile

Table Bach Pharma Overview List

4.8.2 Bach Pharma Products & Services

4.8.3 Bach Pharma Business Operation Conditions

Table Business Operation of Bach Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.9 BrainsGate (Company Profile, Sales Data etc.)

4.9.1 BrainsGate Profile

Table BrainsGate Overview List

4.9.2 BrainsGate Products & Services

4.9.3 BrainsGate Business Operation Conditions

Table Business Operation of BrainsGate (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.10 CarThera (Company Profile, Sales Data etc.)

4.10.1 CarThera Profile

Table CarThera Overview List

4.10.2 CarThera Products & Services

4.10.3 CarThera Business Operation Conditions

Table Business Operation of CarThera (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.11 Dainippon Sumitomo Pharma (Company Profile, Sales Data etc.)

4.11.1 Dainippon Sumitomo Pharma Profile

Table Dainippon Sumitomo Pharma Overview List

4.11.2 Dainippon Sumitomo Pharma Products & Services

4.11.3 Dainippon Sumitomo Pharma Business Operation Conditions

Table Business Operation of Dainippon Sumitomo Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.12 Fluorinov Pharma (Company Profile, Sales Data etc.)

4.12.1 Fluorinov Pharma Profile

Table Fluorinov Pharma Overview List

4.12.2 Fluorinov Pharma Products & Services

4.12.3 Fluorinov Pharma Business Operation Conditions

Table Business Operation of Fluorinov Pharma (Sales Revenue, Cost, Gross Margin)

4.13 Fondazione Telethon (Company Profile, Sales Data etc.)

4.13.1 Fondazione Telethon Profile

Table Fondazione Telethon Overview List

4.13.2 Fondazione Telethon Products & Services

4.13.3 Fondazione Telethon Business Operation Conditions

Table Business Operation of Fondazione Telethon (Sales Revenue, Cost, Gross Margin)

4.14 Minoryx (Company Profile, Sales Data etc.)

4.14.1 Minoryx Profile

Table Minoryx Overview List

4.14.2 Minoryx Products & Services

4.14.3 Minoryx Business Operation Conditions

Table Business Operation of Minoryx (Sales Revenue, Cost, Gross Margin)

4.15 NewGen Therapeutics (Company Profile, Sales Data etc.)

4.15.1 NewGen Therapeutics Profile

Table NewGen Therapeutics Overview List

4.15.2 NewGen Therapeutics Products & Services

4.15.3 NewGen Therapeutics Business Operation Conditions

Table Business Operation of NewGen Therapeutics (Sales Revenue, Cost, Gross Margin)

5 Market Competition

5.1 Company Competition

Table Global Blood-Brain Barrier Transport Drugs Sales Revenue 2015-2019, by Company, in USD Million

Table Global Blood-Brain Barrier Transport Drugs Sales Revenue Share 2015-2019, by Company, in USD Million

Figure Global Blood-Brain Barrier Transport Drugs Sales Revenue Share in 2019, by Company, in USD Million

Table Global Blood-Brain Barrier Transport Drugs Sales Volume 2015-2019, by Company, in Volume

Table Global Blood-Brain Barrier Transport Drugs Sales Volume Share 2015-2019, by Company, in Volume

Figure Global Blood-Brain Barrier Transport Drugs Sales Volume Share in 2019, by Company, in Volume

5.2 Regional Market by Company

Figure North America Blood-Brain Barrier Transport Drugs Market Concentration, in 2019

Figure Europe Blood-Brain Barrier Transport Drugs Market Market Concentration, in 2019

Figure Asia-Pacific Blood-Brain Barrier Transport Drugs MMarket Concentration, in 2019

Figure South America Blood-Brain Barrier Transport Drugs Market Concentration, in 2019

Figure Middle East & Africa Blood-Brain Barrier Transport Drugs Market Concentration, in 2019

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Alzheimer's Disease

Figure Blood-Brain Barrier Transport Drugs Demand in Alzheimer's Disease, 2015-2019, in USD Million

Figure Blood-Brain Barrier Transport Drugs Demand in Alzheimer's Disease, 2015-2019, in Volume

6.1.2 Demand in Epilepsy

Figure Blood-Brain Barrier Transport Drugs Demand in Epilepsy, 2015-2019, in USD Million

Figure Blood-Brain Barrier Transport Drugs Demand in Epilepsy, 2015-2019, in Volume

6.1.3 Demand in Parkinson's Disease

Figure Blood-Brain Barrier Transport Drugs Demand in Parkinson's Disease, 2015-2019, in USD Million

Figure Blood-Brain Barrier Transport Drugs Demand in Parkinson's Disease, 2015-2019, in Volume

6.1.4 Demand in Multiple Sclerosis

Figure Blood-Brain Barrier Transport Drugs Demand in Multiple Sclerosis, 2015-2019, in USD Million

Figure Blood-Brain Barrier Transport Drugs Demand in Multiple Sclerosis, 2015-2019, in Volume

6.1.5 Demand in Hunter's Syndrome

Figure Blood-Brain Barrier Transport Drugs Demand in Hunter's Syndrome, 2015-2019, in USD Million

Figure Blood-Brain Barrier Transport Drugs Demand in Hunter's Syndrome, 2015-2019, in Volume

6.1.6 Demand in Brain Cancer

Figure Blood-Brain Barrier Transport Drugs Demand in Brain Cancer, 2015-2019, in USD Million

Figure Blood-Brain Barrier Transport Drugs Demand in Brain Cancer, 2015-2019, in Volume

6.1.7 Demand in Others

Figure Blood-Brain Barrier Transport Drugs Demand in Others, 2015-2019, in USD Million

Figure Blood-Brain Barrier Transport Drugs Demand in Others, 2015-2019, in Volume

6.2 Regional Demand Comparison

Table Regional Demand Comparison List

Table Major Application in Different Regions

6.3 Demand Forecast

Table Blood-Brain Barrier Transport Drugs Demand Forecast 2020-2025, by Application, in USD Million

Figure Blood-Brain Barrier Transport Drugs Market Growth 2020-2025, by Application, in USD Million

Figure Blood-Brain Barrier Transport Drugs Market Share in 2025, by Application, in USD Million

Table Blood-Brain Barrier Transport Drugs Demand Forecast 2020-2025, by Application, in Volume

Table Blood-Brain Barrier Transport Drugs Market Growth 2020-2025, by Application, in Volume

Table Blood-Brain Barrier Transport Drugs Market Share in 2025, by Application, in Volume

7 Region Operation

7.1 Regional Production

Table Blood-Brain Barrier Transport Drugs Production 2015-2019, by Region, in USD Million

Table Blood-Brain Barrier Transport Drugs Production 2015-2019, by Region, in Volume

7.2 Regional Market

Table Global Blood-Brain Barrier Transport Drugs Market 2015-2019, by Region, in USD Million

Table Global Blood-Brain Barrier Transport Drugs Market Share 2015-2019, by Region, in USD Million

Table Global Blood-Brain Barrier Transport Drugs Market 2015-2019, by Region, in Volume

Table Global Blood-Brain Barrier Transport Drugs Market Share 2015-2019, by Region, in Volume

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

Figure North America Blood-Brain Barrier Transport Drugs Market Size and Growth 2015-2019, in USD Million

Figure North America Blood-Brain Barrier Transport Drugs Market Size and Growth 2015-2019, in Volume

7.3.1.2 by Country (U.S., Canada, Mexico)

Table North America Blood-Brain Barrier Transport Drugs Market Size 2015-2019, by Country, in USD Million

Table North America Blood-Brain Barrier Transport Drugs Market Size 2015-2019, by Country, in Volume

7.3.2 Europe

7.3.2.1 Overview

Figure Europe Blood-Brain Barrier Transport Drugs Market Size and Growth 2015-2019, in USD Million

Figure Europe Blood-Brain Barrier Transport Drugs Market Size and Growth 2015-2019, in Volume

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

Table Europe Blood-Brain Barrier Transport Drugs Market Size 2015-2019, by Country, in USD Million

Table Europe Blood-Brain Barrier Transport Drugs Market Size 2015-2019, by Country, in Volume

7.3.3 Asia-Pacific

7.3.3.1 Overview

Figure Asia-Pacific Blood-Brain Barrier Transport Drugs Market Size and Growth 2015-2019, in USD Million

Figure Asia-Pacific Blood-Brain Barrier Transport Drugs Market Size and Growth 2015-2019, in Volume

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

Table Asia-Pacific Blood-Brain Barrier Transport Drugs Market Size 2015-2019, by Country, in USD Million

Table Asia-Pacific Blood-Brain Barrier Transport Drugs Market Size 2015-2019, by Country, in Volume

7.3.4 South America

7.3.4.1 Overview

Figure South America Blood-Brain Barrier Transport Drugs Market Size and Growth 2015-2019, in USD Million

Figure South America Blood-Brain Barrier Transport Drugs Market Size and Growth 2015-2019, in Volume

7.3.4.2 by Country (Brazil, Argentina etc.)

Table South America Blood-Brain Barrier Transport Drugs Market Size 2015-2019, by Country, in USD Million

Table South America Blood-Brain Barrier Transport Drugs Market Size 2015-2019, by Country, in Volume

7.3.5 Middle East & Africa

7.3.5.1 Overview

Figure Middle East & Africa Blood-Brain Barrier Transport Drugs Market Size and Growth 2015-2019, in USD Million

Figure Middle East & Africa Blood-Brain Barrier Transport Drugs Market Size and Growth 2015-2019, in Volume

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

Table Middle East & Africa Blood-Brain Barrier Transport Drugs Market Size 2015-2019, by Country, in USD Million

Table Middle East & Africa Blood-Brain Barrier Transport Drugs Market Size 2015-2019, by Country, in Volume

7.4 Regional Import & Export

7.5 Regional Forecast

Table Blood-Brain Barrier Transport Drugs Market Forecast 2020-2025, by Region, in USD Million

Table Blood-Brain Barrier Transport Drugs Market Forecast 2020-2025, by Region, in Volume

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

Table Price Factors List

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

Figure Marketing Channels Overview

9 Research Conclusion

List of Table